TW202440611A - 多肽抑制劑、其製備方法和應用 - Google Patents

多肽抑制劑、其製備方法和應用 Download PDF

Info

Publication number
TW202440611A
TW202440611A TW112146695A TW112146695A TW202440611A TW 202440611 A TW202440611 A TW 202440611A TW 112146695 A TW112146695 A TW 112146695A TW 112146695 A TW112146695 A TW 112146695A TW 202440611 A TW202440611 A TW 202440611A
Authority
TW
Taiwan
Prior art keywords
amino acid
alkyl
integers
compound
add
Prior art date
Application number
TW112146695A
Other languages
English (en)
Chinese (zh)
Inventor
董加強
文勝 俞
陳遠
程寶
龔珍
Original Assignee
大陸商上海翰森生物醫藥科技有限公司
大陸商江蘇豪森藥業集團有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商上海翰森生物醫藥科技有限公司, 大陸商江蘇豪森藥業集團有限公司 filed Critical 大陸商上海翰森生物醫藥科技有限公司
Publication of TW202440611A publication Critical patent/TW202440611A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
TW112146695A 2022-11-30 2023-11-30 多肽抑制劑、其製備方法和應用 TW202440611A (zh)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CN202211530438 2022-11-30
CN2022115304381 2022-11-30
CN2023102062995 2023-03-03
CN202310206299 2023-03-03
CN202310261818 2023-03-15
CN2023102618188 2023-03-15
CN202310349519 2023-03-31
CN202310349519X 2023-03-31
CN2023111444895 2023-09-05
CN202311144489 2023-09-05

Publications (1)

Publication Number Publication Date
TW202440611A true TW202440611A (zh) 2024-10-16

Family

ID=91323029

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112146695A TW202440611A (zh) 2022-11-30 2023-11-30 多肽抑制劑、其製備方法和應用

Country Status (10)

Country Link
US (1) US20260193294A1 (cg-RX-API-DMAC7.html)
EP (1) EP4628499A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025540765A (cg-RX-API-DMAC7.html)
KR (1) KR20250111134A (cg-RX-API-DMAC7.html)
CN (1) CN120202212A (cg-RX-API-DMAC7.html)
AU (1) AU2023404553A1 (cg-RX-API-DMAC7.html)
IL (1) IL321139A (cg-RX-API-DMAC7.html)
MX (1) MX2025006152A (cg-RX-API-DMAC7.html)
TW (1) TW202440611A (cg-RX-API-DMAC7.html)
WO (1) WO2024114762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025242221A1 (zh) * 2024-05-24 2025-11-27 上海翰森生物医药科技有限公司 新型修饰侧链、其制备方法和应用
WO2026013260A1 (en) 2024-07-12 2026-01-15 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
WO2026052109A1 (zh) * 2024-09-06 2026-03-12 上海翰森生物医药科技有限公司 一种多肽抑制剂的药物组合物及其用途
WO2026057052A1 (zh) * 2024-09-14 2026-03-19 深圳信立泰药业股份有限公司 一种il-23受体抑制剂及其制备方法和用途
WO2026138829A1 (zh) * 2024-12-23 2026-07-02 上海医药集团股份有限公司 多肽抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201810154WA (en) * 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
EP4021919A1 (en) 2019-08-30 2022-07-06 Merck Sharp & Dohme Corp. Pcsk9 antagonist compounds
US12577259B2 (en) 2019-12-20 2026-03-17 Merck Sharp & Dohme Llc PCSK9 antagonist compounds
MX2022008740A (es) * 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
SMT202500254T1 (it) * 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie
AU2021383828A1 (en) * 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor

Also Published As

Publication number Publication date
IL321139A (en) 2025-07-01
JP2025540765A (ja) 2025-12-16
MX2025006152A (es) 2025-07-01
CN120202212A (zh) 2025-06-24
US20260193294A1 (en) 2026-07-09
AU2023404553A1 (en) 2025-07-10
WO2024114762A1 (zh) 2024-06-06
KR20250111134A (ko) 2025-07-22
EP4628499A1 (en) 2025-10-08

Similar Documents

Publication Publication Date Title
EP4628499A1 (en) Polypeptide inhibitor, and preparation method therefor and use thereof
JP7460541B2 (ja) アシネトバクター・バウマンニ(Acinetobacter baumannii)に対するペプチド大環状分子
CA2410662C (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
JP2024525732A (ja) インターロイキン-23受容体の脂質化ペプチド阻害剤
CA3226492A1 (en) Bicyclic peptide inhibitors of interleukin-23 receptor
CN112236169A (zh) 靶向循环蛋白质的选择性降解的双功能小分子
MX2011006244A (es) Nuevos peptidos de 4-amino-4-oxobutanoilo como inhibidores de replica viral.
US20050119305A1 (en) Il-6 production inhibitors
RU2668791C2 (ru) АНАЛОГИ АЛЬФА- и ГАММА-MSH
CA2418204A1 (en) Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
BRPI0714343A2 (pt) peptÍdeos de 4-amino-4-oxobutanoil como inibidores de replicaÇço viral
JP2010519339A (ja) Hcv複製阻害剤として有用な三級アミン置換ペプチド
CZ2003487A3 (cs) Inhibitory alfa 4 zprostředkované buněčné adheze
TW200845981A (en) Compounds and compositions as channel activating protease inhibitors
CN101279955A (zh) 作为二肽肽激酶-iv抑制剂的n-取代硫吗啉衍生物及其医药用途
TW202327620A (zh) 一種抗炎症的化合物及其用途
TWI345465B (en) Proteasome inhibitors and methods of using the same
KR20260007614A (ko) 인터루킨-23 수용체의 펩타이드 억제제의 제조 및 이의 용도
KR20010075496A (ko) 치환된1,3-디아릴-2-피리딘-2-일-3-(피리딘-2-일아미노)-프로판올유도체, 이의 제조방법, 이를 함유하는 약제학적 조성물및 이의 용도
WO2001021583A1 (en) Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
CN101379076A (zh) 新化合物
CN109180649B (zh) 一种含吲哚环的ido抑制剂及其制备方法
CN116367866A (zh) 蛋白质-药物偶联物的合成方法
CN114746087A (zh) 新的经取代的亚砜亚胺衍生物
JP7734891B2 (ja) 新規な構造を有するポリペプチド薬物複合体及びその使用